Abstract:You have accessJournal of UrologyBenign Prostatic Hyperplasia: Basic Research1 Apr 2015MP31-04 CD8+ T CELLS PROMOTE PROLIFERATION OF BENIGN PROSTATIC HYPERPLASIA EPITHELIAL CELLS IN THE CONDITION OF LOW ANDROGEN Yang Yang, Shuai Hu, Yu Fan, Yun Cui, Mengkui Sun, and Jie Jin Yang YangYang Yang More articles by this author , Shuai HuShuai Hu More articles by this author , Yu FanYu Fan More articles by this author , Yun CuiYun Cui More articles by this author , Mengkui SunMengkui Sun More articles by this author , and Jie JinJie Jin More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2015.02.1359AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Clinical studies suggested that androgen might be associated with infiltrating T cells in prostate of benign prostatic hyperplasia (BPH) patients. Previous studies of our laboratory (data from 64 cases of BPH patients with/without finasteride treatment) have shown that low intra-prostatic dihydrotestosterone (DHT) induced the BPH epithelial cells to recruit CD8+ T cells via modulation of CCL5 secretion. However, the consequences of CD8+ T cells towards prostate tissues remained unclear. Therefore,the present study aimed to investigate the effects of CD8+ T cells on BPH epithelial cells in low DHT condition. METHODS In vitro co-culture system was used to detect impacts of CD8+ T cell line--Molt-3 cells on the BPH epithelial cell line--Bph-1 cells in the low level of DHT condition (medium was treated with 10% charcoal fetal bovine serum). Then during a 4-day co-culture, the Bph-1 cells growth status were detected by CCK8 assay and Brdu immunocytochemistry staining assay. Meanwhile, the expression of Proliferating Cell Nuclear Antigen (PCNA) was analyzed in Bph-1 cells by western blot assay. RESULTS It's observed from CCK8 assay showed that Molt-3 cells could significantly promote Bph-1 cells proliferation in the low DHT condition after the 4-day co-culture compared with Bph-1 cells cultured alone on day 2 and day 4 (day 2: p<0.01, day 4: p<0.01). Furthermore, the Brdu immunocytochemistry staining assay was also showed that the Brdu expression was higher in Bph-1 cells which co-cultured with Molt-3 cells. Finally, the western blot results confirmed that PCNA was up-regulated in Bph-1 cells after co-culture with Molt-3 cells in the low DHT condition. CONCLUSIONS In conclusions, our findings suggested that infiltrating CD8+ T cells could promote the proliferation of BPH epithelial cells in low androgen condition which might provide new insights for a new therapeutic that anti-inflammation therapy combined with anti-DHT therapy in patients with BPH may be warranted in the future. © 2015 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 193Issue 4SApril 2015Page: e356 Advertisement Copyright & Permissions© 2015 by American Urological Association Education and Research, Inc.MetricsAuthor Information Yang Yang More articles by this author Shuai Hu More articles by this author Yu Fan More articles by this author Yun Cui More articles by this author Mengkui Sun More articles by this author Jie Jin More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Functional Interaction of Fibroblast Growth Factor 8b and Androgen in Prostate Cancer Cell Proliferation

Establishment of an Androgen-independent Prostate Cancer Cell Line Induced by the Combined of Flutamide and Androgen-free Environment

Androgen and Epidermal Growth Factor Down-Regulate Cyclin-Dependent Kinase Inhibitor P27kip1 and Costimulate Proliferation of MDA PCa 2a and MDA PCa 2b Prostate Cancer Cells.

Fibroblast growth factor pathway promotes glycolysis by activating LDHA and suppressing LDHB in a STAT1-dependent manner in prostate cancer

FGF21 facilitates autophagy in prostate cancer cells by inhibiting the PI3K–Akt–mTOR signaling pathway

Interactions between androgen and IGF1 axes in prostate tumorigenesis

EGR1 Promotes Proliferation in Prostatic Hyperplasia Epithelial BPH-1 Cells

MS4A8B promotes cell proliferation in prostate cancer.

Growth And Differentiation Factor-9 Promotes Adhesive And Motile Capacity Of Prostate Cancer Cells By Up-Regulating Fak And Paxillin Via Smad Dependent Pathway

Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor.

CD8+ T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway

Pituitary tumor transforming gene binding factor (PBF) is required for androgen-induced prostate cancer proliferation and invasion

ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes

Androgen Receptor in Human Prostate Cancer-Associated Fibroblasts Promotes Prostate Cancer Epithelial Cell Growth and Invasion

Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells

Overexpression of FGF9 in Prostate Epithelial Cells Augments Reactive Stroma Formation and Promotes Prostate Cancer Progression

Ectopic fibroblast growth factor receptor 1 promotes inflammation by promoting nuclear factor-κB signaling in prostate cancer cells

Fibroblast Growth Factor Receptor 2 Tyrosine Kinase is Required for Prostatic Morphogenesis and the Acquisition of Strict Androgen Dependency for Adult Tissue Homeostasis

Mp31-04 cd8+ t cells promote proliferation of benign prostatic hyperplasia epithelial cells in the condition of low androgen

The FGF/FGFR system in the physiopathology of the prostate gland

Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP